Alterations in the cortical serotonergic system in schizophrenia: a postmortem study

Biol Psychiatry. 1997 Oct 1;42(7):529-45. doi: 10.1016/S0006-3223(97)00321-1.

Abstract

Previous studies have suggested a disturbance in the cortical serotonergic (5-HT) system in schizophrenia; however, these studies have been confounded by suicide in the patients groups, which in itself is associated with alterations in the 5-HT system. In this study we characterized various components of the 5-HT system in 14 areas of the frontal and parietal cortex in tissue obtained at postmortem from aged chronically hospitalized nonsuicidal schizophrenics compared to age-matched controls. We found no differences between control and schizophrenic subjects in the density of 5-HT uptake sites or other markers of 5-HT innervation. In Brodmann areas 24 and 6 the concentration of 5-HT2A,C receptors was decreased in all schizophrenics regardless of their antipsychotic treatment history. In all other areas examined 5-HT2A,C receptor concentrations were dramatically decreased in schizophrenics patients on drugs at time of death, whereas those off drugs at death showed the same values as control subjects. The density of 5-HT1A receptors was increased in areas 24, 9a (caudal part of area 9), 44, and 6 in subjects with schizophrenia. Antipsychotic treatment did not appear to have a significant effect. Thus, the specific pattern of alterations in the 5-HT system in schizophrenia may depend on the patient population and on antemortem antipsychotic treatment. These data also provide evidence that regulation of the 5-HT2 receptor may be involved in antipsychotic action.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Autopsy
  • Autoradiography
  • Brain Chemistry / drug effects
  • Brain Chemistry / physiology
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Cerebral Cortex / physiopathology*
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Prefrontal Cortex / metabolism
  • Prefrontal Cortex / pathology
  • Prefrontal Cortex / physiopathology
  • Radioligand Assay
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Dopamine D3
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / metabolism
  • Schizophrenia / drug therapy
  • Schizophrenia / metabolism
  • Schizophrenia / physiopathology*
  • Serotonin / metabolism*

Substances

  • Antipsychotic Agents
  • DRD3 protein, human
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Receptors, Serotonin
  • Serotonin